MacroGenics
MGNX
122 hedge funds and large institutions have $266M invested in MacroGenics in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 45 reducing their positions, and 21 closing their positions.
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.05% less ownership
Funds ownership: 92.91% → 91.86% (-1%)
2% less funds holding
Funds holding: 124 → 122 (-2)
17% less call options, than puts
Call options by funds: $380K | Put options by funds: $456K
29% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 45
46% less capital invested
Capital invested by funds: $495M → $266M (-$229M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.33M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.77M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.18M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.65M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$12.8M |
| 2 |
Millennium Management
New York
|
-$6.23M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
-$3.57M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.26M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.16M |
MGNX Hedge Fund Activity: Q1 2020 in Review
122 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2020, worth a combined $266M — down 46% from $495M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new MGNX positions and 21 closed out — a net gain of 1 holder — while 32 added to existing stakes and 45 trimmed.
The largest buyer was Ameriprise, adding an estimated $4.33M. The largest seller was Sofinnova Investments, exiting entirely with an estimated $12.8M sold.
- 122 institutional investors held MacroGenics (MGNX) as of Q1 2020, down from 124 in Q4 2019.
- Funds reported $266M of MacroGenics stock for Q1 2020, down 46% quarter-over-quarter.
- 22 funds opened new MacroGenics positions in Q1 2020 and 21 closed out, a net change of +1 holder.
- The largest MacroGenics buyer in Q1 2020 was Ameriprise, an estimated $4.33M added.
- The largest MacroGenics seller in Q1 2020 was Sofinnova Investments, an estimated $12.8M sold.
Based on aggregated 13F filings for Q1 2020.